Trial Profile
(68)Ga-DOTA (0)-Tyr (3)-octreotide positron emission tomography in nasopharyngeal carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATATE (Primary)
- Indications Epstein-Barr virus infections; Nasopharyngeal cancer
- Focus Therapeutic Use
- 06 Dec 2015 New trial record